MENLO PARK, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology ...

Alcon issued a global recall of CyPass Micro-Stent and advised surgeons to immediately stop implanting the device in patients after reviewing long-term safety data, Verdict Medical Devices reports. 1.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...

The Food and Drug Administration recently approved the CyPass Micro-Stent for the treatment of glaucoma. The stent, produced by Fort Worth, Texas-based Alcon, is a micro-invasive surgical device used ...

Canaloplasty has emerged as a viable surgical intervention for the management of open-angle glaucoma, offering an alternative to traditional procedures such as trabeculectomy. This non-penetrating ...

Glaucoma can be treated with eye drops, pills, laser surgery, traditional incisional surgery, newer minimally invasive surgical alternatives or a combination of these methods. The goal of any ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and ...

John A. Moran Eye Center alumnus Iqbal "Ike" Ahmed, MD, FRCSC, will tell you he is not afraid of controversy. "Challenge the norm. Challenge what we do…but do it respectfully," Ahmed advised residents ...